Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinodh N Rajapakse

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Science Advances|August 25, 2020
Phenotype stability under dynamic brain-tumor environment stimuli maps glioblastoma progression in patientsVinodh N Rajapakse, Sylvia Herrada, Orit Lavi
Cancer Research|February 5, 2017
Temozolomide in the Era of Precision MedicineAnish Thomas, Mamoru Tanaka, Jane Trepel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2018
Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (<i>SLFN11)</i> Expression with Class I Histone Deacetylase InhibitorsSai-Wen Tang, Anish Thomas, Junko Murai, et al.
BMC Proceedings|May 11, 2011
Nonlinear gene cluster analysis with labeling for microarray gene expression data in organ developmentMartin Ehler, Vinodh N Rajapakse, Barry R Zeeberg, et al.
Human Genetics|September 13, 2014
Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancerWilliam C Reinhold, Sudhir Varma, Vinodh N Rajapakse, et al.
Bioinformatics (Oxford, England)|December 5, 2015
rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in RAugustin Luna, Vinodh N Rajapakse, Fabricio G Sousa, et al.
Molecular Cancer Therapeutics|August 13, 2017
TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient TumorsMuthana Al Abo, Hiroyuki Sasanuma, Xiaojun Liu, et al.
Virchows Archiv : an International Journal of Pathology|June 1, 2020
Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seqTsuyoshi Takashima, Naoya Sakamoto, Junko Murai, et al.
Nucleic Acids Research|November 16, 2020
CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomicsAugustin Luna, Fathi Elloumi, Sudhir Varma, et al.
Cancer Research Communications|November 16, 2022
Replication stress defines distinct molecular subtypes across cancersNobuyuki Takahashi, Sehyun Kim, Christopher W Schultz, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Science Advances|August 25, 2020
Phenotype stability under dynamic brain-tumor environment stimuli maps glioblastoma progression in patientsVinodh N Rajapakse, Sylvia Herrada, Orit Lavi
Cancer Research|February 5, 2017
Temozolomide in the Era of Precision MedicineAnish Thomas, Mamoru Tanaka, Jane Trepel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2018
Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (<i>SLFN11)</i> Expression with Class I Histone Deacetylase InhibitorsSai-Wen Tang, Anish Thomas, Junko Murai, et al.
BMC Proceedings|May 11, 2011
Nonlinear gene cluster analysis with labeling for microarray gene expression data in organ developmentMartin Ehler, Vinodh N Rajapakse, Barry R Zeeberg, et al.
Human Genetics|September 13, 2014
Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancerWilliam C Reinhold, Sudhir Varma, Vinodh N Rajapakse, et al.
Bioinformatics (Oxford, England)|December 5, 2015
rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in RAugustin Luna, Vinodh N Rajapakse, Fabricio G Sousa, et al.
Molecular Cancer Therapeutics|August 13, 2017
TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient TumorsMuthana Al Abo, Hiroyuki Sasanuma, Xiaojun Liu, et al.
Virchows Archiv : an International Journal of Pathology|June 1, 2020
Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seqTsuyoshi Takashima, Naoya Sakamoto, Junko Murai, et al.
Nucleic Acids Research|November 16, 2020
CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomicsAugustin Luna, Fathi Elloumi, Sudhir Varma, et al.
Cancer Research Communications|November 16, 2022
Replication stress defines distinct molecular subtypes across cancersNobuyuki Takahashi, Sehyun Kim, Christopher W Schultz, et al.
Pageof 3